Clinical Trials Browser

Phase 2 × Gastrointestinal Stromal Tumors × pazopanib × Clear all

NCT02342600 2017-10-12

SARC029: Trametinib and Pazopanib in Patients With GIST (Gastrointestinal Stromal Tumor)

Phase 2 Withdrawn

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01524848 2017-05-10

PAGIST

Phase 2 Completed

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors

NCT01391611 2017-04-07

Pazopanib in Imatinib Refractory or Intolerant Gastrointestinal Stromal Tumors (GIST)

Phase 2 Terminated

25 enrolled 7 charts

GastrointestinalSarcoma

Gastrointestinal Stromal Tumors